43 results
Page 2 of 3
8-K
EX-99.1
d920bi2hjhwl0
15 Nov 21
ENDRA Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update
4:18pm
8-K
EX-99.1
om46hcxi0w33um5
12 Aug 21
ENDRA Life Sciences Reports Second Quarter 2021 Financial Results and Provides Business Update
4:06pm
8-K
EX-99.1
aorehb3uevk1ashi77r
15 Jun 21
ENDRA Life Sciences Appoints Irina Pestrikova as Senior Director of Finance, Announces Departure of CFO David Wells
9:01am
8-K
EX-99.1
oca04 equlah9701ytqo
17 May 21
ENDRA Life Sciences Reports First Quarter 2021 Financial Results and Provides Business Update
4:05pm
8-K
EX-99.1
1xbjuog1 x1v4l
25 Mar 21
ENDRA Life Sciences Reports 2020 Fourth Quarter and Full Year Financial Results, Provides Business Update
12:00am
8-K
EX-99.1
onibpwxwk5i0zlyqm8j
21 Dec 20
ENDRA Life Sciences Extends GE Healthcare Collaboration Agreement for Two Years
5:18pm
8-K
EX-99.2
yjx7mg5zrohq
18 Dec 20
ENDRA Life Sciences Announces Proposed Public Offering of Common Stock
5:04pm
8-K
EX-99.1
wi6x1qh
18 Dec 20
ENDRA Life Sciences Announces Proposed Public Offering of Common Stock
5:04pm
8-K
EX-99.3
p2dj7d2zkp4tzpnyzq
18 Dec 20
ENDRA Life Sciences Announces Proposed Public Offering of Common Stock
5:04pm
8-K
EX-99.1
py4rj18t1wyuda570
16 Nov 20
ENDRA Life Sciences Reports Third Quarter 2020 Financial Results and Provides Business Update
4:05pm
8-K
EX-99.1
2ppnx3aw w4fc92ul
17 Aug 20
ENDRA Life Sciences Provides Business Update and Reports Second Quarter 2020 Financial Results
4:02pm
8-K
EX-99.1
roenw
14 May 20
ENDRA Life Sciences Provides Business Update and Reports First Quarter 2020 Financial Results
4:04pm
8-K
EX-99.1
shes9 mc2q8709cs
13 Apr 20
ENDRA Life Sciences Announces Cash Strategy and Business Update in Response to COVID-19
4:29pm
8-K
EX-99.1
gui90rg0wc cgk
26 Mar 20
ENDRA Life Sciences Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
4:07pm
8-K
EX-99.1
oz0k0ku8d y5594ebf
10 Mar 20
ENDRA Life Sciences Receives CE Mark for its TAEUS® Clinical Product Targeting Non-Alcoholic Fatty Liver Disease
8:02am
8-K
EX-99.1
zvqhl1s
15 Jan 20
ENDRA Life Sciences Renews GE Healthcare Collaboration Agreement
10:12am
8-K
EX-99.1
ge2bdvyyl 44ioqqce2v
11 Dec 19
ENDRA Life Sciences Completes $8.1 Million Private Placement
5:14pm
8-K
EX-99.1
68w5uv
13 Nov 19
ENDRA Life Sciences Provides Business Update and Reports Third Quarter 2019 Financial Results
4:05pm